Preserving access to medications for patients with Serious Mental Illness Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings
HR 1329 - Medicaid Reentry Act
S.1983, CREATE Opportunities Act, H.R. 3496 CREATE Opportunities Act
H.R. 1158, FY20 Consolidated Appropriations Act (PL-116-93)
H.R. 1865, FY20 Further Consolidated Appropriations Act (PL 116-94)
H.R. 133, Consolidated Appropriations Act, 2021 (PL 116-260) Awareness of the need for treatment system reform and access to all FDA-approved medications
Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments
Awareness of outcomes data and the need for training on all medication assisted treatment
Initiatives to promote the use of relapse prevention post detoxification
SUPPORT for Patient and Communities Act (PL 115-271)
S. 3312/HR 5909 - Crisis Stabilization and Community Reentry Act
S. 2690, Restoring, Enhancing, Securing, and Promoting Our Nation's Safety Efforts Act of 2019 Maintain six protected classes for depressions and schizophrenia under Medicare Part D
Drug pricing issues - HR3 - Lower Drug Costs Now Act; S2543 - Prescription Drug Pricing Reduction Act;
H.R. 19 - Lower Costs, More Cures Act of 2019;
H.R. 133 - Consolidated Appropriations Act, 2021 (PL 116-260) - Maintain Medicaid rebates for MAT products;
SUPPORT Act (PL 115-271) - Maintain Medicaid rebates for MAT products;
LAW - Law Enforcement/Crime/Criminal Justice ALC - Alcohol and Drug Abuse HCR - Health Issues MMM - Medicare/Medicaid
155 - Drug Enforcement Administration (DEA) 11 - Executive Office of the President (EOP) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 139 - Natl Institutes of Health (NIH) 19 - Office of Natl Drug Control Policy (NDCP) 1 - SENATE 141 - Substance Abuse & Mental Health Services Administration (SAMHSA) 42 - Veterans Affairs, Dept of (VA) 155 - Drug Enforcement Administration (DEA) 11 - Executive Office of the President (EOP) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 139 - Natl Institutes of Health (NIH) 19 - Office of Natl Drug Control Policy (NDCP) 1 - SENATE 141 - Substance Abuse & Mental Health Services Administration (SAMHSA) 42 - Veterans Affairs, Dept of (VA) 155 - Drug Enforcement Administration (DEA) 11 - Executive Office of the President (EOP) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 139 - Natl Institutes of Health (NIH) 19 - Office of Natl Drug Control Policy (NDCP) 1 - SENATE 141 - Substance Abuse & Mental Health Services Administration (SAMHSA) 42 - Veterans Affairs, Dept of (VA) 155 - Drug Enforcement Administration (DEA) 11 - Executive Office of the President (EOP) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 139 - Natl Institutes of Health (NIH) 19 - Office of Natl Drug Control Policy (NDCP) 1 - SENATE 141 - Substance Abuse & Mental Health Services Administration (SAMHSA) 42 - Veterans Affairs, Dept of (VA)
ALKERMES, INC.
900 Winter Street, Waltham, MA, 02451, US
PETER NORMAN MEGAN JACKSON PETER NORMAN MEGAN JACKSON ROBERT FORMAN KRISTI THOMPSON PETER NORMAN MEGAN JACKSON ROBERT FORMAN KRISTI THOMPSON PETER NORMAN MEGAN JACKSON ROBERT FORMAN KRISTI THOMPSON